RELA and neoplasm: When total tumour cell p-p65 was stratified by molecular subtype (Figure 2B-2E) the association between total tumour cell p-p65 and cancer-specific survival was lost in patients with Luminal A disease (Figure 2B)(P=0.712) (10 year survival, 90% vrs 92%, P=0.930) and in patients with HER2 enriched disease (Figure 2E) (P=0.992) (10 year survival, 67% vrs 59%, P=0.865).